A detailed history of Lpl Financial LLC transactions in Vericel Corp stock. As of the latest transaction made, Lpl Financial LLC holds 44,406 shares of VCEL stock, worth $2.62 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
44,406
Previous 36,953 20.17%
Holding current value
$2.62 Million
Previous $1.7 Million 10.68%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$42.25 - $53.56 $314,889 - $399,182
7,453 Added 20.17%
44,406 $1.88 Million
Q2 2024

Aug 07, 2024

BUY
$41.71 - $52.9 $1.17 Million - $1.49 Million
28,080 Added 316.47%
36,953 $1.7 Million
Q1 2024

May 10, 2024

SELL
$32.52 - $52.33 $59,153 - $95,188
-1,819 Reduced 17.01%
8,873 $461,000
Q4 2023

Feb 14, 2024

SELL
$30.85 - $37.09 $20,052 - $24,108
-650 Reduced 5.73%
10,692 $380,000
Q3 2023

Nov 13, 2023

BUY
$31.69 - $39.25 $94,879 - $117,514
2,994 Added 35.86%
11,342 $380,000
Q2 2023

Jul 31, 2023

BUY
$29.0 - $38.37 $15,022 - $19,875
518 Added 6.62%
8,348 $313,000
Q1 2023

May 10, 2023

SELL
$23.85 - $31.34 $208,687 - $274,225
-8,750 Reduced 52.77%
7,830 $229,000
Q4 2022

Feb 07, 2023

SELL
$17.65 - $27.37 $48,731 - $75,568
-2,761 Reduced 14.28%
16,580 $436,000
Q3 2022

Nov 14, 2022

SELL
$22.62 - $32.54 $6,672 - $9,599
-295 Reduced 1.5%
19,341 $449,000
Q2 2022

Aug 12, 2022

BUY
$22.88 - $39.45 $25,762 - $44,420
1,126 Added 6.08%
19,636 $494,000
Q1 2022

May 16, 2022

BUY
$31.69 - $43.29 $32,925 - $44,978
1,039 Added 5.95%
18,510 $707,000
Q4 2021

Feb 14, 2022

SELL
$35.2 - $52.6 $14,819 - $22,144
-421 Reduced 2.35%
17,471 $687,000
Q3 2021

Nov 15, 2021

BUY
$46.35 - $59.75 $170,985 - $220,417
3,689 Added 25.97%
17,892 $873,000
Q2 2021

Aug 13, 2021

BUY
$47.2 - $67.81 $109,362 - $157,115
2,317 Added 19.49%
14,203 $746,000
Q1 2021

May 14, 2021

BUY
$30.93 - $59.48 $367,633 - $706,979
11,886 New
11,886 $660,000

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.79B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Lpl Financial LLC Portfolio

Follow Lpl Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.